Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGFR | P43088 | 14/20 | 0.66 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.66 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.66 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.52 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.52 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13327764 | 0.97 | PTGFR (0.66) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327739 | 0.94 | PTGFR (0.66) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL12119613 | 0.94 | PTGFR (0.73) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327765 | 0.93 | PTGFR (0.66) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327762 | 0.93 | PTGFR (0.69) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327748 | 0.92 | PTGFR (0.66) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327998 | 0.92 | PTGFR (0.69) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327767 | 0.92 | PTGFR (0.68) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327958 | 0.91 | PTGFR (0.68) | PTGFRPTGER3ABCC4ABCB11TBXA2R | |
| SCHEMBL13327804 | 0.91 | ABCC4 (0.65) | PTGFRPTGER3ABCC4ABCB11TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718656-B2 | Prostaglandin derivatives | NICOX S.A. (FR) | 2010-05-18 | — | — | US | disclosed |
| US-20090062296-A1 | Prostaglandin derivatives | AGOURON PHARMACEUTICALS, INC. | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062296-A1 | Prostaglandin derivatives | PTGIS, PTGIR, PTGS1 | PTGFR 16/4885PTGER3 15/4885ABCC4 1836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.